1. Home
  2. CDT vs MSGM Comparison

CDT vs MSGM Comparison

Compare CDT & MSGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • MSGM
  • Stock Information
  • Founded
  • CDT 2019
  • MSGM 2018
  • Country
  • CDT United States
  • MSGM United States
  • Employees
  • CDT N/A
  • MSGM N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • MSGM Computer Software: Prepackaged Software
  • Sector
  • CDT Health Care
  • MSGM Technology
  • Exchange
  • CDT Nasdaq
  • MSGM Nasdaq
  • Market Cap
  • CDT 5.2M
  • MSGM 5.7M
  • IPO Year
  • CDT N/A
  • MSGM 2021
  • Fundamental
  • Price
  • CDT $0.54
  • MSGM $2.41
  • Analyst Decision
  • CDT
  • MSGM Hold
  • Analyst Count
  • CDT 0
  • MSGM 1
  • Target Price
  • CDT N/A
  • MSGM $5.00
  • AVG Volume (30 Days)
  • CDT 7.4M
  • MSGM 2.2M
  • Earning Date
  • CDT 05-13-2025
  • MSGM 05-06-2025
  • Dividend Yield
  • CDT N/A
  • MSGM N/A
  • EPS Growth
  • CDT N/A
  • MSGM N/A
  • EPS
  • CDT N/A
  • MSGM N/A
  • Revenue
  • CDT N/A
  • MSGM $8,687,462.00
  • Revenue This Year
  • CDT N/A
  • MSGM $69.07
  • Revenue Next Year
  • CDT N/A
  • MSGM $30.56
  • P/E Ratio
  • CDT N/A
  • MSGM N/A
  • Revenue Growth
  • CDT N/A
  • MSGM 25.73
  • 52 Week Low
  • CDT $0.51
  • MSGM $0.73
  • 52 Week High
  • CDT $350.00
  • MSGM $3.75
  • Technical
  • Relative Strength Index (RSI)
  • CDT 36.40
  • MSGM 72.60
  • Support Level
  • CDT $0.52
  • MSGM $0.83
  • Resistance Level
  • CDT $1.01
  • MSGM $2.47
  • Average True Range (ATR)
  • CDT 0.16
  • MSGM 0.37
  • MACD
  • CDT 0.02
  • MSGM 0.17
  • Stochastic Oscillator
  • CDT 3.43
  • MSGM 70.87

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About MSGM Motorsport Games Inc.

Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.

Share on Social Networks: